BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29140491)

  • 21. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Mendoza TR; Williams LA; Keating KN; Siegel J; Elbi C; Nowak AK; Hassan R; Cuffel B; Cleeland CS
    J Patient Rep Outcomes; 2019 Jun; 3(1):34. PubMed ID: 31209661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese version of the MD Anderson Symptom Inventory: a validation study.
    Okuyama T; Wang XS; Akechi T; Mendoza TR; Hosaka T; Cleeland CS; Uchitomi Y
    J Pain Symptom Manage; 2003 Dec; 26(6):1093-104. PubMed ID: 14654261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of common symptoms of cancer and reliability analysis.
    Zhao Y; Wang XS; Li PP
    Chin J Integr Med; 2007 Sep; 13(3):195-9. PubMed ID: 17898950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
    Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
    BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
    Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients.
    Wang XS; Laudico AV; Guo H; Mendoza TR; Matsuda ML; Yosuico VD; Fragante EP; Cleeland CS
    J Pain Symptom Manage; 2006 Jun; 31(6):542-52. PubMed ID: 16793494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Spanish version of the MD Anderson symptom inventory - heart failure (MDASI-HF-Spanish) module.
    Fadol A; Buitrago J; Diaz MC; Shelton V; Harty C; Mendoza TR
    Cardiooncology; 2019; 5():19. PubMed ID: 32154025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients.
    Saadatpour L; Hemati S; Habibi F; Behzadi E; Hashemi-Jazi MS; Kheirabadi G; Mirbagher L; Gholamrezaei A
    J Pain Symptom Manage; 2015 Sep; 50(3):387-393.e1. PubMed ID: 25980966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
    Kamal M; Navai N; Bree KK; Williams LA; Cleeland CS; Shen SE; Wang XS
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).
    Armstrong TS; Mendoza T; Gning I; Coco C; Cohen MZ; Eriksen L; Hsu MA; Gilbert MR; Cleeland C
    J Neurooncol; 2006 Oct; 80(1):27-35. PubMed ID: 16598415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
    Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
    J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
    Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
    J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients.
    Mystakidou K; Cleeland C; Tsilika E; Katsouda E; Primikiri A; Parpa E; Vlahos L; Mendoza T
    Oncology; 2004; 67(3-4):203-10. PubMed ID: 15557779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module.
    Piil K; Whisenant M; Mendoza T; Armstrong T; Cleeland C; Nordentoft S; Williams LA; Jarden M
    Neurooncol Pract; 2021 Apr; 8(2):137-147. PubMed ID: 33898047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
    Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
    Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients.
    Lin CC; Chang AP; Cleeland CS; Mendoza TR; Wang XS
    J Pain Symptom Manage; 2007 Feb; 33(2):180-8. PubMed ID: 17280923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory.
    Ivanova MO; Ionova TI; Kalyadina SA; Uspenskaya OS; Kishtovich AV; Guo H; Mendoza TR; Novik A; Cleeland CS; Wang XS
    J Pain Symptom Manage; 2005 Nov; 30(5):443-53. PubMed ID: 16310618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.
    Fadol A; Mendoza T; Gning I; Kernicki J; Symes L; Cleeland CS; Lenihan D
    J Card Fail; 2008 Aug; 14(6):497-507. PubMed ID: 18672198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
    Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
    J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.